Table 4 Antibiotic susceptibility profiles of isolated Lactobacillus strains.

From: Anti-oral cancer properties of potential probiotic lactobacilli isolated from traditional milk, cheese, and yogurt

Isolated Strains

Antibiotics

CFM

AZM

AMX

D

SXT

CP

CN

AMC

V

C5

0.00 ± 0.00b

0.00 ± 0.00a

0.00 ± 0.00c

14.68 ± 1.18d

0.00 ± 0.00a

16.47 ± 0.62b

10.52 ± 1.26d

18.58 ± 0.38d

0.00 ± 0.00b

C28

16.44 ± 0.72a

0.00 ± 0.00a

0.00 ± 0.00c

46.24 ± 0.66a

0.00 ± 0.00a

0.00 ± 0.00c

31.84 ± 0.40a

32.70 ± 1.04a

20.14 ± 0.46a

M45

0.00 ± 0.00b

0.00 ± 0.00a

20.60 ± 0.33b

31.52 ± 1.22c

0.00 ± 0.00a

0.00 ± 0.00c

15.30 ± 1.48b

24.92 ± 0.74c

0.00 ± 0.00b

Y33

0.00 ± 0.00b

0.00 ± 0.00a

25.28 ± 0.66a

42.48 ± 0.84b

0.00 ± 0.00a

20.16 ± 0.27a

12.62 ± 0.55c

28.90 ± 0.48b

0.00 ± 0.00b

  1. CFM, cefixime; AZM, azithromycin; AMX, amoxicillin; D, doxycycline; SXT, trimethoprim sulfamethoxazole; CP, ciprofloxacin; CN, cephalexin; AMC, amoxicillin–clavulanic acid; V, vancomycin. Cefixime results based on R ≤ 15 mm; I: 16–18 mm; S ≥ 19 mm. Azithromycin results based on R ≤ 13 mm; I: 14–17 mm; S ≥ 18 mm. Amoxicillin results based on R ≤ 18 mm; I: 19–21 mm; S ≥ 22 mm. Doxycycline results based on R ≤ 10 mm; I: 11–13 mm; S ≥ 14 mm. Trimethoprim sulfamethoxazole results based on R ≤ 25 mm; I: 26–29 mm; S ≥ 30 mm. Ciprofloxacin results based on R ≤ 15 mm; I: 16–20 mm; S ≥ 21 mm. Cephalexin results based on R ≤ 14 mm; I: 15–17 mm; S ≥ 18 mm. Amoxicillin–clavulanic acid results based on R ≤ 13 mm; I: 14–17 mm; S ≥ 18 mm. Vancomycin results based on R ≤ 14 mm; I: 15–16 mm; S ≥ 17 mm. Performance Standards for Antimicrobial Susceptibility Testing, from Clinical and Laboratory Standards Institute, Twenty-Third Informational Supplement, Wayne, PA (CLSI 2013).
  2. *Values are mean ± standard error of triplicates. a–eMeans in the same row with different lowercase letters differed significantly (P < 0.05).